Nelson Jennifer Ann 4
4 · Omega Therapeutics, Inc. · Filed Nov 26, 2024
Insider Transaction Report
Form 4
Nelson Jennifer Ann
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-11-22+110,000→ 110,000 totalExercise: $0.79Exp: 2034-11-21→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable with respect to 25% of the underlying shares on November 15, 2025 and in twelve (12) equal quarterly installments thereafter such that the option will become fully vested and exercisable on November 15, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date.